A. Bakker

1.9k total citations
44 papers, 1.2k citations indexed

About

A. Bakker is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Bakker has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Bakker's work include Clinical Laboratory Practices and Quality Control (11 papers), Thyroid Disorders and Treatments (6 papers) and Electrolyte and hormonal disorders (5 papers). A. Bakker is often cited by papers focused on Clinical Laboratory Practices and Quality Control (11 papers), Thyroid Disorders and Treatments (6 papers) and Electrolyte and hormonal disorders (5 papers). A. Bakker collaborates with scholars based in Netherlands, Australia and Germany. A. Bakker's co-authors include E. Christiaan Boerma, Rik Gerritsen, Peter H. J. van der Voort, M.G. Woldring, J.P.M.C. Gorgels, Jennichjen Slomp, Michaël Kuiper, Bob van Vlies, Peter H. J. van der Voort and A Jansz and has published in prestigious journals such as The Lancet, Diabetes Care and European Heart Journal.

In The Last Decade

A. Bakker

44 papers receiving 1.2k citations

Peers

A. Bakker

CCM

NEPHR

EPIDE

SURGE

EDM

M Mestre Spain

Raymond Lepage Canada

Claude Jacobs France

Iris Kingma Canada

J Zazgórnik Austria

Ralf Dikow Germany

N.P. Mallick United Kingdom

Giovanni Pellegrini Italy

Rosalia Aloe Italy

J. D. Briggs United Kingdom

M Mestre Spain

A. Bakker

451 ×1.4

CCM

803 ×2.9

NEPHR

290 ×1.3

EPIDE

276 ×1.3

SURGE

139 ×0.7

EDM

Citations per year, relative to A. Bakker A. Bakker (= 1×) peers M Mestre

Countries citing papers authored by A. Bakker

Since Specialization

Citations

This map shows the geographic impact of A. Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bakker more than expected).

Fields of papers citing papers by A. Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bakker. The network helps show where A. Bakker may publish in the future.

Co-authorship network of co-authors of A. Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bakker. A scholar is included among the top collaborators of A. Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bakker. A. Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buter, Hanneke, A. Bakker, W. Peter Kingma, Matty Koopmans, & E. Christiaan Boerma. (2015). Plasma glutamine levels in patients after non-elective or elective ICU admission: an observational study. BMC Anesthesiology. 16(1). 15–15. 9 indexed citations

Bakker, A., et al.. (2009). HbA1c measurements from dried blood spots: validation and patient satisfaction. Clinical Chemistry and Laboratory Medicine (CCLM). 47(10). 1259–64. 59 indexed citations

Boerma, E. Christiaan, Matty Koopmans, A. Bakker, et al.. (2009). Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: A double-blind randomized placebo controlled trial. Critical Care Medicine. 38(1). 93–100. 147 indexed citations

Bakker, A., et al.. (2009). Screening for M-proteinemia: serum protein electrophoresis and free light chains compared. Clinical Chemistry and Laboratory Medicine (CCLM). 47(12). 1507–11. 7 indexed citations

Bakker, A., et al.. (2007). Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clinical Chemistry and Laboratory Medicine (CCLM). 45(9). 1240–3. 53 indexed citations

Voort, Peter H. J. van der, Sonja Postma, W. Peter Kingma, et al.. (2007). An Observational Study on the Effects of Nadroparin-Based and Citrate-Based Continuous Venovenous Hemofiltration on Calcium Metabolism. Blood Purification. 25(3). 267–273. 11 indexed citations

Bakker, A., et al.. (2006). Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clinical Chemistry and Laboratory Medicine (CCLM). 44(8). 962–6. 59 indexed citations

Ajubi, N.E., A. Bakker, & G. A. Berg. (2006). Determination of the length of sedimentation reaction in blood using the TEST 1 system: comparison with the Sedimatic 100 method, turbidimetric fibrinogen levels, and the influence of M-proteins. Clinical Chemistry and Laboratory Medicine (CCLM). 44(7). 904–6. 10 indexed citations

Bakker, A., et al.. (2006). Cellular content in plasma of Becton-Dickinson lithium-heparin tubes: cause of unreliable results in the IFCC-recommended lactate dehydrogenase method. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 43(6). 510–512. 6 indexed citations

10.

Han, Renzhi & A. Bakker. (2005). The effect of the PKC inhibitor calphostin C and the PKC agonist phorbol 12-myristate 13-acetate on regulation of cytosolic Ca2+ in mammalian skeletal muscle cells. Toxicology and Applied Pharmacology. 212(3). 247–255. 2 indexed citations

11.

Bakker, A., et al.. (2004). Improved Reliability of Measurement of Lactate Dehydrogenase by IFCC Method in Heparin Plasma. Clinical Chemistry. 51(1). 215–217. 2 indexed citations

12.

Bakker, A., et al.. (2003). IFCC Method for Lactate Dehydrogenase Measurement in Heparin Plasma Is Unreliable. Clinical Chemistry. 49(4). 662–664. 14 indexed citations

13.

Slomp, Jennichjen, et al.. (2003). Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill. Critical Care Medicine. 31(5). 1389–1393. 87 indexed citations

14.

Dijs, Fey P.L. van der, John‐John B. Schnog, D.A. Janneke Dijck‐Brouwer, et al.. (1998). Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. American Journal of Hematology. 59(3). 192–198. 54 indexed citations

15.

Bakker, A., et al.. (1995). Exclusion of Acute Myocardial Infarction. The Value of Measuring Creatine Kinase Slope. Clinical Chemistry and Laboratory Medicine (CCLM). 33(6). 351–364. 3 indexed citations

16.

Bakker, A., et al.. (1994). Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction. European Heart Journal. 15(1). 45–53. 60 indexed citations

17.

Bakker, A.. (1993). Failure of new biochemical markers to exclude acute myocardial infarction at admission. The Lancet. 342(8881). 1220–1222. 104 indexed citations

18.

Bakker, A., et al.. (1993). The Mass Concentrations of Serum Troponin T and Creatine Kinase-MB are Elevated before Creatine Kinase and Creatine Kinase-MB Activities in Acute Myocardial Infarction. Clinical Chemistry and Laboratory Medicine (CCLM). 31(11). 715–24. 25 indexed citations

19.

Bakker, A., et al.. (1988). Determining iron without copper interference from carryover of total protein reagent in Hitachi analyzers.. Clinical Chemistry. 34(11). 2376–2376. 1 indexed citations

20.

Boer, Jan de, et al.. (1987). A simpler enzymatic determination of creatine in serum with a commercial creatinine kit.. Clinical Chemistry. 33(5). 720–720. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact